ClinicalTrials.Veeva

Menu
A

Activian Clinical Research | Kingwood, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Orforglipron
LY3502970
LY3298176
Tirzepatide
Bimagrumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 6 total trials

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

The purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants w...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Orforglipron
Locations recently updated

The main purpose of this study is to see how orforglipron, compared with placebo, helps reduce body weight in participants with obesity or with overw...

Enrolling
Overweight
Obesity
Drug: Orforglipron
Drug: Placebo

The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron work...

Enrolling
Osteoarthritis
Drug: Orforglipron
Drug: Placebo

Trial sponsors

Lilly logo
H
Moderna logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems